These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17055323)

  • 1. Calcium channel blockers and beta-blockers in relation to Parkinson's disease.
    Ton TG; Heckbert SR; Longstreth WT; Rossing MA; Kukull WA; Franklin GM; Swanson PD; Smith-Weller T; Checkoway H
    Parkinsonism Relat Disord; 2007 Apr; 13(3):165-9. PubMed ID: 17055323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium channel blocker use and risk of Parkinson's disease: a meta-analysis.
    Lang Y; Gong D; Fan Y
    Pharmacoepidemiol Drug Saf; 2015 Jun; 24(6):559-66. PubMed ID: 25845582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β2-adrenoceptor agonists and antagonists and risk of Parkinson's disease.
    Gronich N; Abernethy DR; Auriel E; Lavi I; Rennert G; Saliba W
    Mov Disord; 2018 Sep; 33(9):1465-1471. PubMed ID: 30311974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive drugs and the risk of incident rosacea.
    Spoendlin J; Voegel JJ; Jick SS; Meier CR
    Br J Dermatol; 2014 Jul; 171(1):130-6. PubMed ID: 24428524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive medications and risk of community-acquired pneumonia.
    Mukamal KJ; Ghimire S; Pandey R; O'Meara ES; Gautam S
    J Hypertens; 2010 Feb; 28(2):401-5. PubMed ID: 20051911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-type calcium channel blockers and Parkinson disease in Denmark.
    Ritz B; Rhodes SL; Qian L; Schernhammer E; Olsen JH; Friis S
    Ann Neurol; 2010 May; 67(5):600-6. PubMed ID: 20437557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Shock Index a Valid Predictor of Mortality in Emergency Department Patients With Hypertension, Diabetes, High Age, or Receipt of β- or Calcium Channel Blockers?
    Kristensen AK; Holler JG; Hallas J; Lassen A; Shapiro NI
    Ann Emerg Med; 2016 Jan; 67(1):106-113.e6. PubMed ID: 26144893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years.
    Li CI; Malone KE; Weiss NS; Boudreau DM; Cushing-Haugen KL; Daling JR
    Cancer; 2003 Oct; 98(7):1504-13. PubMed ID: 14508839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.
    Rejnmark L; Vestergaard P; Mosekilde L
    J Hypertens; 2006 Mar; 24(3):581-9. PubMed ID: 16467662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term use of antihypertensive drugs and risk of cancer.
    Assimes TL; Elstein E; Langleben A; Suissa S
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1039-49. PubMed ID: 18780400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-channel blockers and risk of cancer.
    Jick H; Jick S; Derby LE; Vasilakis C; Myers MW; Meier CR
    Lancet; 1997 Feb; 349(9051):525-8. PubMed ID: 9048789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium channel blocker use and risk of Parkinson's disease.
    Simon KC; Gao X; Chen H; Schwarzschild MA; Ascherio A
    Mov Disord; 2010 Sep; 25(12):1818-22. PubMed ID: 20669249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
    Vaughan TL; Farrow DC; Hansten PD; Chow WH; Gammon MD; Risch HA; Stanford JL; Schoenberg JB; Mayne ST; Rotterdam H; Dubrow R; Ahsan H; West AB; Blot WJ; Fraumeni JF
    Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):749-56. PubMed ID: 9752982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pesticides and risk of Parkinson disease: a population-based case-control study.
    Firestone JA; Smith-Weller T; Franklin G; Swanson P; Longstreth WT; Checkoway H
    Arch Neurol; 2005 Jan; 62(1):91-5. PubMed ID: 15642854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cigarette smoking and Parkinson's disease: a case-control study in a population characterized by a high prevalence of pesticide exposure.
    Galanaud JP; Elbaz A; Clavel J; Vidal JS; Corrèze JR; Alpérovitch A; Tzourio C
    Mov Disord; 2005 Feb; 20(2):181-9. PubMed ID: 15468111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic eczematous eruptions in the aging: further support for an association with exposure to calcium channel blockers.
    Summers EM; Bingham CS; Dahle KW; Sweeney C; Ying J; Sontheimer RD
    JAMA Dermatol; 2013 Jul; 149(7):814-8. PubMed ID: 23636109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease.
    Ton TG; Heckbert SR; Longstreth WT; Rossing MA; Kukull WA; Franklin GM; Swanson PD; Smith-Weller T; Checkoway H
    Mov Disord; 2006 Jul; 21(7):964-9. PubMed ID: 16550541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL; Baker WL; White CM
    Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of antihypertensives and the risk of Parkinson disease.
    Becker C; Jick SS; Meier CR
    Neurology; 2008 Apr; 70(16 Pt 2):1438-44. PubMed ID: 18256367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constipation is reduced by beta-blockers and increased by dopaminergic medications in Parkinson's disease.
    Pagano G; Tan EE; Haider JM; Bautista A; Tagliati M
    Parkinsonism Relat Disord; 2015 Feb; 21(2):120-5. PubMed ID: 25483722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.